Phase 2 Head and Neck Cancer Trial, Recruiting (NCT06982300)

Phase 2 Head and Neck Cancer Trial, Recruiting NCT06982300 Sponsor: University Medical Center Groningen Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06982300 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with nasopharyngeal cancer (a type of cancer in the back of the nose/throat) at a certain stage (Stage IB to IVA), and your cancer has tested positive for a virus called Epstein-Barr virus (EBV)
Your doctors are planning to treat you with chemotherapy before radiation, or with chemotherapy and radiation together
You are 18 years of age or older
You are willing and able to follow all the steps and procedures required by the trial
You have signed a form agreeing to take part (informed consent)
If you are a woman who could become pregnant, you have had a negative pregnancy test before joining
You either have stored tumor tissue available from a previous biopsy, or you agree to have a new tumor biopsy done

Who may not be able to join:

You have already received chemotherapy or radiation treatment for this type of cancer
You have taken part in another clinical trial or received an experimental treatment within the last 28 days
You have another serious illness, condition, or abnormal test result that could affect the trial results or put you at higher risk of complications (confirm with trial site)
You have a condition affecting your mental health or thinking that would prevent you from fully understanding and agreeing to take part
You are unable to lie flat on your back for 25 minutes
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06982300

Sponsor: University Medical Center Groningen

Phase: Phase 2

Status: Recruiting

Condition: Head and Neck Cancer

More information: https://clinicaltrials.gov/study/NCT06982300

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with nasopharyngeal cancer (a type of cancer in the back of the nose/throat) at a certain stage (Stage IB to IVA), and your cancer has tested positive for a virus called Epstein-Barr virus (EBV)
Your doctors are planning to treat you with chemotherapy before radiation, or with chemotherapy and radiation together
You are 18 years of age or older
You are willing and able to follow all the steps and procedures required by the trial
You have signed a form agreeing to take part (informed consent)
If you are a woman who could become pregnant, you have had a negative pregnancy test before joining
You either have stored tumor tissue available from a previous biopsy, or you agree to have a new tumor biopsy done

Who may not be able to join:

You have already received chemotherapy or radiation treatment for this type of cancer
You have taken part in another clinical trial or received an experimental treatment within the last 28 days
You have another serious illness, condition, or abnormal test result that could affect the trial results or put you at higher risk of complications (confirm with trial site)
You have a condition affecting your mental health or thinking that would prevent you from fully understanding and agreeing to take part
You are unable to lie flat on your back for 25 minutes
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University Medical Center Groningen

Registry

ClinicalTrials.gov

Start date

25 September 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Feasibility of assessing tumor SSTR2 expression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov